SMAD3 and cancer: Therapeutically, Smad3 inhibitor significantly suppresses MMT in LLC tumors, contributing to the anticancer effect of SIS3 previously reported by our group.[6] In this study, we discovered a pathogenic role for MMT in cancer by promoting CAF formation directly from TAM governing by Smad3.